Nasdaq · Common Stock · Laboratory Analytical Instruments
American company that develops systems for the analysis of genetic variation
44 entities across 32 jurisdictions. Read directly from the company’s own 10-K EX-21 filed 2026-02-12 — see the exhibit.
Which other public companies file entities in the same places:
| Entity | Jurisdiction | Note |
|---|---|---|
| Advanced Liquid Logic Inc. | Delaware | |
| BlueBee Holding BV | Netherlands | |
| Emedgene Technologies Ltd | Israel | |
| Fluent Biosciences Inc. | Delaware | |
| Illumina AB | Sweden | |
| Illumina Australia Pty. Ltd. | Australia | |
| Illumina Austria GmbH | Austria | |
| Illumina Belgium BV | Belgium | |
| Illumina Brasil Produtos de Biotecnologia Ltda. | Brazil | |
| Illumina Cambridge, Ltd. | United Kingdom | |
| Illumina Cambridge Limited Singapore Branch | Singapore | |
| Illumina Canada ULC | Canada | |
| Illumina (China) Scientific Co Ltd | China | |
| Illumina (China) Scientific Co., Ltd. – Beijing Branch | China | |
| Illumina (China) Scientific Co., Ltd. – Guangzhou Branch | China | |
| Illumina Colombia S.A.S. | Colombia | |
| Illumina Commercial South Africa (Pty) | South Africa | |
| Illumina Denmark ApS | Denmark | |
| Illumina Diagnostics (Shanghai) Co., Ltd. | China | |
| Illumina Finland Oy | Finland | |
| Illumina France Holding Sarl | France | |
| Illumina France Sarl | France | |
| Illumina GmbH | Germany | |
| Illumina Hong Kong Limited | Hong Kong | |
| Illumina India Biotechnology Private Limited | India | |
| Illumina International Genomics Pte. Ltd. | Singapore | |
| Illumina Ireland Commercial Limited | Ireland | |
| Illumina Italy S.r.l. | Italy | |
| Illumina K.K. | Japan | |
| Illumina MENA Regional Headquarters | Saudi Arabia | |
| Illumina México Productos de Biotecnología, S. de R.L. de C.V. | Mexico | |
| Illumina Middle East FZE | United Arab Emirates | |
| Illumina Netherlands B.V. | Netherlands | |
| Illumina New Zealand Limited | New Zealand | |
| Illumina Norway AS | Norway | |
| Illumina Productos de Espana, S.L.U. | Spain | |
| Illumina Singapore Genomics Pte. Ltd. | Singapore | |
| Illumina Singapore Pte. Ltd. | Singapore | |
| Illumina Software, Inc. | Delaware | |
| Illumina Switzerland GmbH | Switzerland | |
| Illumina US Manufacturing Operations, Inc. | Delaware | |
| Illumina Taiwan Biotechnology Co., Ltd. | Taiwan | |
| Illumina Turkey Biyoteknoloji Limited Sirketii | Turkey | |
| Verinata Health, Inc. | Delaware |
Two standard screens, computed from the XBRL in FY2025 against FY2024. Every test shows the numbers behind it — a score with its inputs hidden is a number you cannot check.
| Year | Revenue | Net income | Free cash flow | Gross margin | Shares |
|---|---|---|---|---|---|
| FY2021 | $3.2B | $656.0M | $891.0M | 68.0% | 148,000,000 |
| FY2022 | $4.5B | $762.0M | $337.0M | 69.7% | 151,000,000 |
| FY2023 | $4.6B | −$4.4B | $106.0M | 64.8% | 157,000,000 |
| FY2023 | $4.5B | −$1.2B | $283.0M | 60.9% | 158,000,000 |
| FY2024 | $4.4B | −$1.2B | $709.0M | 65.4% | 159,000,000 |
| FY2025 | $4.3B | $850.0M | $931.0M | 66.1% | 156,000,000 |
18 institutions tracked — 7 added, 10 reduced, 1 opened a new position.
| Manager | Kind | Shares | Change | Value |
|---|---|---|---|---|
| FMR LLC | Active fund | 4,523,417 | +2,976,556 | $795.4M |
| WELLINGTON MANAGEMENT GROUP LLP | Active fund | 1,812,928 | +1,188,004 | $318.8M |
| AQR CAPITAL MANAGEMENT LLC | Hedge fund | 3,544,465 | −436,615 | $623.2M |
| BAILLIE GIFFORD & CO | Value | 1,335,846 | −199,260 | $234.9M |
| MORGAN STANLEY | Active fund | 1,654,664 | −188,948 | $290.9M |
| BlackRock, Inc. | Index | 19,191,398 | +167,808 | $3.4B |
| JPMORGAN CHASE & CO | Active fund | 1,181,215 | +149,862 | $213.9M |
| RENAISSANCE TECHNOLOGIES LLC | Hedge fund | 826,642 | −146,000 | $145.3M |
| Capital World Investors | Active fund | 15,425,298 | −124,662 | $2.7B |
| GEODE CAPITAL MANAGEMENT, LLC | Index | 2,946,669 | −104,610 | $516.7M |
| ARK Investment Management LLC | Active fund | 1,045,010 | −84,449 | $183.7M |
| STATE STREET CORP | Index | 6,507,288 | +77,944 | $1.1B |
| BANK OF AMERICA CORP /DE/ | Active fund | 1,455,287 | −61,342 | $255.9M |
| CITADEL ADVISORS LLC | Hedge fund | 169,300 | −46,200 | $29.8M |
| Point72 Asset Management, L.P. | Hedge fund | 95,500 | +18,800 | $16.8M |
| PRICE T ROWE ASSOCIATES INC /MD/ | Active fund | 158,914 | +9,717 | $27.9M |
| Bridgewater Associates, LP | Hedge fund | 12,586 | −165 | $2.2M |
NORGES BANK holds a position with no prior filing to compare against, so its change is unknown rather than zero — and it is left out of the totals above.
From 13F filings, which cover institutions managing over $100m and are filed up to 45 days after the quarter ends — so this is a considered position, not a live one, and it is not the whole shareholder register.
What the company actually paid out and bought back, as reported — the record behind any yield figure.
Ownership percentages are a vendor aggregate, not a filing — unlike everything else on this page.
ILLUMINA, INC. files under SIC 3826 — all 12 laboratory analytical instruments companies compared on assets and F-score.
The structure map above is the Corporate Blueprint, and in the desktop it is interactive — click any entity to re-centre the map on it and walk the ownership chain. It sits alongside the screener, the scorecard and the filings lab on one desk, on your machine.
Sourced from SEC EDGAR primary filings. Figures are as reported by the company and are not investment advice. Scores are standard published screens computed from those filings; every input is shown above so you can check the arithmetic.
